Data / Form D filings / LifeCyte Innovations, Inc.
LifeCyte Innovations, Inc.: Form D filing
LifeCyte Innovations, Inc., a pharmaceuticals company in Greensboro, GA, filed a Form D with the SEC in 2026. The latest, on August 20, 2026, reports $1 million sold of a $5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1221 ACORN KNOB, Greensboro, GA, 30642
- Phone
- (319) 899-1858
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Iowa
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2150601
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 3 | Aug 12, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth Brown | Executive Officer, Director | |
| Michael Moorhead | Executive Officer, Director |
Other pharmaceuticals companies in Georgia that filed recently
- Laurentide Therapeutics Inc. $99,999 · Sep 28, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in Georgia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LifeCyte Innovations, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.